TECregen raised CHF10M with Boehringer Ingelheim Venture Fund, Zürcher Kantonal Bank, Lifespan Vision Ventures, Carma Fund, JFG Life Sciences, HTGF Biotech Health services Manufacturing Investments 08 December 2025 Share: Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!
Round value (USD): 12.44M Round investors: Boehringer Ingelheim Venture FundLifespan Vision VenturesHigh-Tech GründerfondsJFG Life Sciences FoundationZürcher KantonalbankCarma Fund Company: TECregen Industry: BiotechHealth servicesManufacturing
Liom in a CHF 13 million series A extension with Red Bull Ventures and Swiss angel investors Hardware Health services Manufacturing Software Services Investments 03 December 2025
Virometix secured $15 million in a financing round supported by existing shareholders. Biotech Health services Investments 03 November 2025
Indivi in a CHF 15 million equity finance round led by Ava Investors Biotech Hardware Health services Software Services Wearable Investments 17 October 2025